|
Re: It will be surprising to me....
|
8
|
Resverlogix Corp.
|
Aug 08, 2018 09:48AM
|
|
Re: Special Report on Drug Delivery: Penetrating the Impenetrable
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 08, 2018 11:03AM
|
|
Re: Rebuys start at $2.28
|
5
|
Resverlogix Corp.
|
Aug 09, 2018 05:38PM
|
|
Re: Rebuys start at $2.28
|
5
|
Resverlogix Corp.
|
Aug 09, 2018 05:46PM
|
|
Re: Rebuys start at $2.28
|
4
|
Resverlogix Corp.
|
Aug 09, 2018 11:29PM
|
|
Vorapaxar and anti-platelet therapy
|
6
|
Resverlogix Corp.
|
Aug 10, 2018 12:44PM
|
|
Re: China offering fast marketing approvals
|
4
|
Resverlogix Corp.
|
Aug 10, 2018 03:42PM
|
|
Re: China offering fast marketing approvals
|
6
|
Resverlogix Corp.
|
Aug 10, 2018 04:38PM
|
|
Notice of Meeting and Information Circular on SEDAR
|
5
|
Resverlogix Corp.
|
Aug 11, 2018 11:19AM
|
|
Notice of Meeting and Information Circular on SEDAR
|
4
|
Zenith Epigenetics
|
Aug 11, 2018 11:34AM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
4
|
Resverlogix Corp.
|
Aug 11, 2018 12:43PM
|
|
FDA approves Migalastat (Galafold) from Amicus for Fabry disease
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:25PM
|
|
Re: Notice of Meeting and Information Circular on SEDAR
|
3
|
Resverlogix Corp.
|
Aug 11, 2018 01:29PM
|
|
Re: What If - Uses of Apabetalone
|
5
|
Resverlogix Corp.
|
Aug 12, 2018 02:35PM
|
|
Re: What If - Uses of Apabetalone
|
2
|
Resverlogix Corp.
|
Aug 12, 2018 05:34PM
|
|
Re: New shares issued?
|
3
|
Zenith Epigenetics
|
Aug 12, 2018 05:44PM
|
|
Re: Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
3
|
Resverlogix Corp.
|
Aug 13, 2018 11:11AM
|
|
Re: Updated Van Leeuwenhoeck Institute Analyst Report and August Fact Sheet
|
3
|
Resverlogix Corp.
|
Aug 13, 2018 01:01PM
|
|
Re: "57% relative risk reduction of MACE in patients with diabetes mellitus (DM) and CVD..."
|
2
|
Resverlogix Corp.
|
Aug 13, 2018 10:20PM
|
|
ABCA1 overexpression worsens colorectal cancer prognosis and this can be ameliorated by apabetalone
|
7
|
Resverlogix Corp.
|
Aug 14, 2018 09:11AM
|
